Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$528M |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$524M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$331M |
| 4 |
Meta Platforms (Facebook)
META
|
+$277M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$209M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$435M |
| 2 |
Duke Energy
DUK
|
+$412M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$259M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$256M |
| 5 |
Alibaba
BABA
|
+$223M |
Sector Composition
| 1 | Technology | 12.97% |
| 2 | Financials | 12.22% |
| 3 | Healthcare | 10.71% |
| 4 | Communication Services | 7.75% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
2801
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $44K | ﹤0.01% |
71
+1
| +1% | +$620 |
|
2802
Enpro
NPO
$4.64B
| $44K | ﹤0.01% |
662
-5,376
| -89% | -$357K |
|
2803
S&T Bancorp
STBA
$1.5B
| $44K | ﹤0.01% |
1,132
+333
| +42% | +$12.9K |
|
|
BPFH
2804
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $44K | ﹤0.01% |
2,689
+888
| +49% | +$14.5K |
|
2805
Akebia Therapeutics
AKBA
$782M
| $43K | ﹤0.01% |
4,052
+3,704
| +1,064% | +$39.3K |
|
2806
Thermon Group Holdings
THR
$844M
| $43K | ﹤0.01% |
2,253
+1,615
| +253% | +$30.8K |
|
|
ITCI
2807
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $43K | ﹤0.01% |
2,853
+246
| +9% | +$3.71K |
|
|
APEX
2808
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $43K | ﹤0.01% |
137
+32
| +30% | +$10K |
|
2809
Aegon
AEG
$12.2B
| $42K | ﹤0.01% |
9,886
+2,155
| +28% | +$9.16K |
|
|
DEA
2810
Easterly Government Properties
DEA
$1.07B
| $42K | ﹤0.01% |
837
+537
| +179% | +$26.9K |
|
2811
Freshpet
FRPT
$2.67B
| $42K | ﹤0.01% |
4,107
-8,227
| -67% | -$84.1K |
|
2812
StealthGas
GASS
$271M
| $42K | ﹤0.01% |
12,500
| – | – |
|
2813
Inovio Pharmaceuticals
INO
$126M
| $42K | ﹤0.01% |
500
-924
| -65% | -$77.6K |
|
2814
Materion
MTRN
$2.31B
| $42K | ﹤0.01% |
1,029
+556
| +118% | +$22.7K |
|
|
EXAC
2815
DELISTED
Exactech Inc
EXAC
| $42K | ﹤0.01% |
1,549
-2,823
| -65% | -$76.5K |
|
|
ALX
2816
Alexander's
ALX
$1.25B
| $41K | ﹤0.01% |
93
-119
| -56% | -$52.5K |
|
2817
Diodes
DIOD
$2.44B
| $41K | ﹤0.01% |
1,603
-5,199
| -76% | -$133K |
|
2818
LivePerson
LPSN
$86M
| $41K | ﹤0.01% |
5,391
-4,587
| -46% | -$34.9K |
|
2819
Medifast
MED
$154M
| $41K | ﹤0.01% |
984
-6,777
| -87% | -$282K |
|
2820
Syndax Pharmaceuticals
SNDX
$1.34B
| $41K | ﹤0.01% |
5,807
+170
| +3% | +$1.2K |
|
|
AHH
2821
Armada Hoffler Properties
AHH
$596M
| $40K | ﹤0.01% |
2,737
+2,528
| +1,210% | +$36.9K |
|
2822
Cass Information Systems
CASS
$565M
| $40K | ﹤0.01% |
721
+338
| +88% | +$18.8K |
|
2823
Daktronics
DAKT
$1.14B
| $40K | ﹤0.01% |
3,821
+3,083
| +418% | +$32.3K |
|
2824
Eldorado Gold
EGO
$5.7B
| $40K | ﹤0.01% |
2,516
-11,842
| -82% | -$188K |
|
2825
Element Solutions
ESI
$6.36B
| $40K | ﹤0.01% |
4,136
-49
| -1% | -$474 |
|